Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function
NCT01825759 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2013-04-08
Summary
The Impact of Compound danshen dropping pill for coronary heart disease (CHD) heart and artery structure and function in patients with hypertension
Conditions
- Coronary Heart Disease
- Essential Hypertension
Interventions
- DRUG
-
danshen dripping pill
Sponsors & Collaborators
-
West China Hospital
lead OTHER
Principal Investigators
-
chen xi ping, master · organizer
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 35 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- China
Study Locations
More Related Trials
-
Nicotinamide Mononucleotide in Hypertensive Patients
NCT04903210 ·Status: UNKNOWN ·Phase: PHASE4
-
To Assess the Anti-anginal Safety and Efficacy of Ivabradine in Subjects With Stable，Symptomatic Chronic Angina
NCT02623569 ·Status: UNKNOWN ·Phase: PHASE2
-
Real World Assessment of Effects of Beta-blockers on Patients With Acute Coronary Syndrome
NCT03669991 ·Status: UNKNOWN
-
Clinical Trial Scheme of Xinnaoning Capsule
NCT03914131 ·Status: UNKNOWN ·Phase: PHASE4
-
A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Hypertension
NCT01970059 ·Status: UNKNOWN ·Phase: PHASE3
-
Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart Disease
NCT03887013 ·Status: UNKNOWN ·Phase: PHASE4
-
The Contemporary Role of Beta Blockers in Patients With Acute Myocardial Infarction
NCT04564365 ·Status: UNKNOWN
-
Dietary Nitrate and Physiological Aging
NCT02593305 ·Status: COMPLETED ·Phase: NA
-
Influence of the Autonomic Nervous System in Response to Exercise in Hypertensive Individuals
NCT04371757 ·Status: UNKNOWN ·Phase: NA
-
A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Heart Failure
NCT02012075 ·Status: UNKNOWN ·Phase: PHASE3
-
Real-world Use and Prognosis of Beta Blocker in Patients With Acute Coronary Syndrome in the Central China
NCT03116854 ·Status: COMPLETED
-
Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries
NCT00829296 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
2019-nCoV Outbreak and Cardiovascular Diseases
NCT04255940 ·Status: UNKNOWN
-
Treatment of Chronic Mountain Sickness
NCT04251364 ·Status: COMPLETED ·Phase: NA
-
pErsonalised Nocebo Assessment of Beta-blockEr Symptoms in Heart Failure
NCT07029906 ·Status: RECRUITING ·Phase: NA
-
The Hemodynamic Response to Prolonged Dobutamine Infusion
NCT01042873 ·Status: UNKNOWN ·Phase: PHASE4
-
The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling
NCT01340326 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris
NCT04270279 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Anxiety on Coronary Microcirculatory Function in Hypertensive Patients
NCT04960371 ·Status: UNKNOWN
-
Influence of Salbutamol on Emotional and Cognitive Functions in Healthy Subjects
NCT01957293 ·Status: COMPLETED ·Phase: PHASE2
-
Autonomic Phenotype Before and After Akt Inhibition
NCT01593579 ·Status: WITHDRAWN
-
The Effect of Beta-blocker on Chronotropic Response and Cardiorespiratory Fitness in Patients With Atrial Fibrillation
NCT05332457 ·Status: RECRUITING ·Phase: NA
-
Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study
NCT04374045 ·Status: COMPLETED
-
Effect of Beta Blockade on Left Ventricular Remodeling and Function in Moderate to Severe Asymptomatic Aortic Regurgitation
NCT01157572 ·Status: COMPLETED ·Phase: PHASE4
-
The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries
NCT00115583 ·Status: COMPLETED ·Phase: NA